Lensar/$LNSR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Lensar
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
- Ticker
- $LNSR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 150
- Headquarters
- Orlando, United States
- Website
- www.lensar.com
Lensar Metrics
BasicAdvanced
$56M
8.07
$0.57
-
-
Price and volume
Market cap
$56M
52-week high
$12.94
52-week low
$4.30
Average daily volume
58K
Financial strength
Current ratio
2.246
Quick ratio
0.921
Long term debt to equity
0.056
Total debt to equity
0.088
Profitability
EBITDA (TTM)
2.504
Gross margin (TTM)
52.03%
Net profit margin (TTM)
56.07%
Operating margin (TTM)
-3.29%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
-1.80%
Return on equity (TTM)
529.32%
Valuation
Price to earnings (TTM)
8.074
Price to revenue (TTM)
0.933
Price to book
5.09
Price to tangible book (TTM)
8.58
Price to free cash flow (TTM)
-11.689
Free cash flow yield (TTM)
-8.56%
Free cash flow per share (TTM)
-0.392
Growth
Revenue change (TTM)
1.59%
Earnings per share change (TTM)
-113.04%
3-year revenue growth (CAGR)
14.25%
3-year earnings per share growth (CAGR)
-22.19%
What the Analysts think about Lensar
Analyst ratings (Buy, Hold, Sell) for Lensar stock.
Analyst projections of the future price of Lensar stock.
Lensar Financial Performance
Revenues and expenses
Lensar Earnings Performance
Company profitability
Upcoming events
No upcoming events
Lensar News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.